New approaches for managing gastro-oesophageal reflux disease (GORD) are evolving, impacting patient outcomes and surgical practices.

• Potassium-competitive acid blockers show higher healing rates and longer acid suppression than proton pump inhibitors.
• Robotic antireflux surgery yields outcomes comparable to traditional laparoscopic methods.
• Novel endoscopic techniques and devices are under evaluation, offering potential alternatives for patient treatment.

Surgeons should adapt to these advancements to enhance personalized care for GORD patients.